Abstract
The management of viral infections is a global healthcare challenge with particular significance in develo** countries. This chapter presents the prevalence, morbidity, and mortality of viral infections in these regions, addressing clinical, economic, and humanistic burdens. Factors contributing to the prevalence of viral infections, such as limited access to healthcare, poor sanitation, and social disparities, are explored alongside strategies for prevention and management. Complications arising from viral infections are discussed, including the impact on healthcare systems and the human cost of these diseases. The clinical presentation and diagnosis of viral infections, guided by evolving healthcare technologies, are highlighted. Goals of therapy, desired outcomes, and the critical role of pharmacological and non-pharmacological interventions in treatment are elucidated. Monitoring parameters and evaluation of therapeutic outcomes underscore the importance of regular assessments. Modifiable causes and risk factors, such as inadequate sanitation and limited vaccination coverage, are addressed alongside recommendations for their mitigation. Treating complications and providing psychosocial support for affected individuals are essential components of comprehensive care. Patient education and counseling, aimed at reducing stigma and promoting prevention, are pivotal in managing viral infections. Telemedicine and online healthcare expand access to diagnosis and treatment, complementing traditional care models. Guidelines, resources, and educational materials from organizations like the World Health Organization (WHO) and national health ministries facilitate evidence-based practice. Despite challenges, achievements in viral infection management are evident, including expanded vaccination programs, improved access to antiretroviral therapy for HIV, and global health partnerships. Recommendations encompass strengthening healthcare infrastructure, expanding telemedicine, enhancing access to medications and vaccines, and promoting cultural competency. Collaborative efforts, both within and beyond national borders, remain central to managing viral infections effectively. This chapter provides an overview of the comprehensive examination of viral infection management in develo** countries, emphasizing the importance of prevention, diagnosis, and treatment strategies. It underscores the significance of collaborative efforts and the potential for progress in improving public health outcomes.
References
Al-Mohamadi, A., Halboup, A. M., Ibrahim, M. I. M., Abdulghani, M., Al-Worafi, Y. M., Otham, G., … & Ansari, M. (2018). Medical and pharmacy students’ perceptions regarding generic medicines in Yemen. Journal of Pharmacy Practice and Community Medicine, 4, 47–50.
Alshahrani, S. M., Alakhali, K. M., & Al-Worafi, Y. M. (2019a). Medication errors in a health care facility in southern Saudi Arabia. Tropical Journal of Pharmaceutical Research, 18(5), 1119–1122.
Alshahrani, S. M., Alavudeen, S. S., Alakhali, K. M., Al-Worafi, Y. M., Bahamdan, A. K., & Vigneshwaran, E. (2019b). Self-medication among King Khalid University students, Saudi Arabia. Risk Management and Healthcare Policy, 12, 243–249.
Al-Worafi, Y. M. (2014a). The challenges of pharmacy education in Yemen. American Journal of Pharmaceutical Education, 78(8), 146.
Al-Worafi, Y. M. (2014b). Pharmacy practice and its challenges in Yemen. The Australasian Medical Journal, 7(1), 17.
Al-Worafi, Y. M. (2014c). Prescription writing errors at a tertiary care hospital in Yemen: Prevalence, types, causes and recommendations. American Journal of Pharmacy and Health Research, 2, 134–140.
Al-Worafi, Y. M. A. (2016). Pharmacy practice in Yemen. In Pharmacy practice in develo** countries (pp. 267–287). Academic.
Al-Worafi, Y. M. (Ed.). (2020a). Drug safety in develo** countries: Achievements and challenges. Academic.
Al-Worafi, Y. M. (2020b). Medications safety research issues. In Drug safety in develo** countries (pp. 213–227). Academic.
Al-Worafi, Y. M. (2020c). Medications safety-related terminology. In Drug safety in develo** countries (pp. 7–19). Academic.
Al-Worafi, Y. M. (2020d). Medications registration and marketing: Safety-related issues. In Drug safety in develo** countries (pp. 21–28). Academic.
Al-Worafi, Y. M. (2020e). Pharmacovigilance. In Drug safety in develo** countries (pp. 29–38). Academic.
Al-Worafi, Y. M. (2020f). Medication errors. In Drug safety in develo** countries (pp. 59–71). Academic.
Al-Worafi, Y. M. (2020g). Adverse drug reactions. In Drug safety in develo** countries (pp. 39–57). Academic.
Al-Worafi, Y. M. (2020h). Self-medication. In Drug safety in develo** countries (pp. 73–86). Academic.
Al-Worafi, Y. M. (2020i). Antibiotics safety issues. In Drug safety in develo** countries (pp. 87–103). Academic.
Al-Worafi, Y. M. (2020j). Drug-related problems. In Drug safety in develo** countries (pp. 105–117). Academic.
Al-Worafi, Y. M. (2020k). Counterfeit and substandard medications. In Drug safety in develo** countries (pp. 119–126). Academic.
Al-Worafi, Y. M. (2020l). Medication abuse and misuse. In Drug safety in develo** countries (pp. 127–135). Academic.
Al-Worafi, Y. M. (2020m). Storage and disposal of medications. In Drug safety in develo** countries (pp. 137–142). Academic.
Al-Worafi, Y. M. (2020n). Safety of medications in special population. In Drug safety in develo** countries (pp. 143–162). Academic.
Al-Worafi, Y. M. (2020o). Herbal medicines safety issues. In Drug safety in develo** countries (pp. 163–178). Academic.
Al-Worafi, Y. M. (2020p). Medications safety pharmacoeconomics-related issues. In Drug safety in develo** countries (pp. 187–195). Academic.
Al-Worafi, Y. M. (2020q). Evidence-based medications safety practice. In Drug safety in develo** countries (pp. 197–201). Academic.
Al-Worafi, Y. M. (2020r). Quality indicators for medications safety. In Drug safety in develo** countries (pp. 229–242). Academic.
Al-Worafi, Y. M. (2020s). Drug safety in Yemen. In Drug safety in develo** countries (pp. 391–405). Academic.
Al-Worafi, Y. M. (2020t). Drug safety in Saudi Arabia. In Drug safety in develo** countries (pp. 407–417). Academic.
Al-Worafi, Y. M. (2020u). Drug safety in United Arab Emirates. In Drug safety in develo** countries (pp. 419–428). Academic.
Al-Worafi, Y. M. (2020v). Drug safety in Indonesia. In Drug safety in develo** countries (pp. 279–285). Academic.
Al-Worafi, Y. M. (2020w). Drug safety in Palestine. In Drug safety in develo** countries (pp. 471–480). Academic.
Al-Worafi, Y. M. (2020x). Drug safety: Comparison between develo** countries. In Drug safety in develo** countries (pp. 603–611). Academic.
Al-Worafi, Y. M. (2020y). Drug safety in develo** versus developed countries. In Drug safety in develo** countries (pp. 613–615). Academic.
Al-Worafi, Y. (2022a). A guide to online pharmacy education: Teaching strategies and assessment methods. CRC Press.
Al-Worafi, Y. (2022b). Competencies and learning outcomes. In A guide to online pharmacy education: Teaching strategies and assessment methods. CRC Press.
Al-Worafi, Y. (2022c). Continuing Professional Development (CPD) and lifelong learning. In A guide to online pharmacy education: Teaching strategies and assessment methods. CRC Press.
Al-Worafi, Y. (2022d). Technologies and tools. In A guide to online pharmacy education: Teaching strategies and assessment methods. CRC Press.
Al-Worafi, Y. (2022e). Pharmacists’ prescribing. In A guide to online pharmacy education: Teaching strategies and assessment methods. CRC Press.
Al-Worafi, Y. (2022f). Patient care. In A guide to online pharmacy education: Teaching strategies and assessment methods. CRC Press.
Al-Worafi, Y. (2023a). Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. M. (2023b). Technology for drug safety: Current status and future developments. Springer Nature.
Al-Worafi, Y. (2023c). Patient safety-related issues: Patient care errors and related problems. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023d). Patient care errors and related problems: Preventive medicine errors & related problems. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023e). Patient care errors and related problems: Patient assessment and diagnostic errors & related problems. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023f). Patient care errors and related problems: Non-pharmacological errors & related problems. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023g). Patient care errors and related problems: Medical errors & related problems. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023h). Patient care errors and related problems: Monitoring errors & related problems. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023i). Patient care errors and related problems: Patient education and counselling errors and related problems. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023j). Patient safety-related issues: Other medication safety issues. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023k). Patient safety culture. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. (2023l). Patient safety education: Competencies and learning outcomes. In Patient safety in develo** countries: Education, research, case studies. CRC Press.
Al-Worafi, Y. M. (Ed.). (2023m). Clinical case studies on medication safety. Academic.
Al-Worafi, Y. M. (Ed.). (2023n). Comprehensive healthcare simulation: Pharmacy education, practice and research. Springer Nature.
Al-Worafi, Y. M. (2023o). Development and validation of the pharmacist care model and definitions. https://doi.org/10.21203/rs.3.rs-3128130/v1
Al-Worafi, Y. M. (2023p). Artificial intelligence and machine learning for drug safety. In Technology for drug safety: Current status and future developments (pp. 69–80). Springer International Publishing.
Al-Worafi, Y. M., Kassab, Y. W., Alseragi, W. M., Almutairi, M. S., Ahmed, A., Ming, L. C., Alkhoshaiban, A. S., & Hadi, M. A. (2017). Pharmacovigilance and adverse drug reaction reporting: A perspective of community pharmacists and pharmacy technicians in Sana’a, Yemen. Therapeutics and Clinical Risk Management, 13, 1175.
Al-Worafi, Y. M., Patel, R. P., Zaidi, S. T. R., Alseragi, W. M., Almutairi, M. S., Alkhoshaiban, A. S., & Ming, L. C. (2018a). Completeness and legibility of handwritten prescriptions in Sana’a, Yemen. Medical Principles and Practice, 27, 290–292.
Al-Worafi, Y. M., Alseragi, W. M., Seng, L. K., Kassab, Y. W., Yeoh, S. F., Chiau, L., … & Husain, K. (2018b). Dispensing errors in community pharmacies: A prospective study in Sana’a, Yemen. Archives of Pharmacy Practice, 9(4), 1–3.
Al-Worafi, Y. M., Alseragi, W. M., Ming, L. C., & Alakhali, K. M. (2020). Drug safety in China. In Drug safety in develo** countries (pp. 381–388). Academic.
Al-Worafi, Y. M., Hermansyah, A., Tan, C. S., Choo, C. Y., Bouyahya, A., Paneerselvam, G. S., … & Ming, L. C. (2023a). Applications, benefits, and risks of ChatGPT in medical and health sciences research: An experimental study. Progress in Microbes & Molecular Biology, 6(1). https://doi.org/10.36877/pmmb.a0000346
Al-Worafi, Y. M., Goh, K. W., Hermansyah, A., Tan, C. S., & Ming, L. C. (2023b). The use of ChatGPT for integrated infectious disease pharmacotherapy module: Educators’ perspectives. JMIR Medical Education. 25/07/2023:47339 (forthcoming/in press).
Atif, M., Munir, K., Malik, I., Al-Worafi, Y. M., Mushtaq, I., & Ahmad, N. (2022). Perceptions of healthcare professionals and patients on the role of the pharmacist in TB management in Pakistan: A qualitative study. Frontiers in Pharmacology, 13, 965806.
Baig, M. R., Al-Worafi, Y. M., Alseragi, W. M., Ming, L. C., & Siddique, A. (2020). Drug safety in India. In Drug safety in develo** countries (pp. 327–334). Academic.
Elangovan, D., Long, C. S., Bakrin, F. S., Tan, C. S., Goh, K. W., Hussain, Z., … & Ming, L. C. (2020). Application of blockchain technology in hospital information system. In Mathematical modeling and soft computing in epidemiology (pp. 231–264). CRC Press.
Elkalmi, R. M., Al-Worafi, Y. M., Alseragi, W. M., Ming, L. C., & Siddique, A. (2020). Drug safety in Malaysia. In Drug safety in develo** countries (pp. 245–253). Academic.
Elsayed, T., & Al-Worafi, Y. M. (2020). Drug safety in Egypt. In Drug safety in develo** countries (pp. 511–523). Academic.
Hasan, S., Al-Omar, M. J., AlZubaidy, H., & Al-Worafi, Y. M. (2019). Use of medications in Arab countries. In Handbook of healthcare in the Arab world (p. 42). Springer.
Jaber, A. A. S., Al-Worafi, Y. M., & Dhabali, A. A. (2022). Patients’ beliefs toward generic medication in Yemen. Journal of Generic Medicines, 18(2), 110–115.
Kharaba, Z., Farhat, J., Mahboub, B. S., Buabeid, M. A., Alfoteih, Y., Al-Worafi, Y., … & Al-Ahmad, M. (2022). Current views of community and hospital pharmacists on pharmaceutical care services in the United Arab Emirates: A mixed methodological study.
Kumaran, H., Long, C. S., Bakrin, F. S., Tan, C. S., Goh, K. W., Al-Worafi, Y. M., … & Ming, L. C. (2020). Online pharmacies: Desirable characteristics and regulations. Drugs & Therapy Perspectives, 36, 243–245.
Lee, K. S., Yee, S. M., Zaidi, S. T. R., Patel, R. P., Yang, Q., Al-Worafi, Y. M., & Ming, L. C. (2017). Combating sale of counterfeit and falsified medicines online: A losing battle. Frontiers in Pharmacology, 8, 268.
Mahmoud, M. A., Wajid, S., Naqvi, A. A., Samreen, S., Althagfan, S. S., & Al-Worafi, Y. (2020). Self-medication with antibiotics: A cross-sectional community-based study. Latin American Journal of Pharmacy, 39(2), 348–353.
Ming, L. C., Hameed, M. A., Lee, D. D., Apidi, N. A., Lai, P. S. M., Hadi, M. A., Al-Worafi, Y. M. A., & Khan, T. M. (2016). Use of medical mobile applications among hospital pharmacists in Malaysia. Therapeutic Innovation & Regulatory Science, 50(4), 419–426.
Saeed, M. S., Alkhoshaiban, A. S., Al-Worafi, Y. M. A., & Long, C. M. (2014). Perception of self-medication among university students in Saudi Arabia. Archives of Pharmacy Practice, 5(4), 149.
Saher, T., Al-Worafi, Y. M., Iqbal, M. N., Wahid, A., Iqbal, Q., Khan, A., … & Ahmad, N. (2022). Doctors’ adherence to guidelines recommendations and glycaemic control in diabetic patients in Quetta, Pakistan: Findings from an observational study. Frontiers in Medicine, 9, 978345.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 Springer Nature Switzerland AG
About this entry
Cite this entry
Al-Worafi, Y.M. (2024). Viral Infection Management in Develo** Countries. In: Al-Worafi, Y.M. (eds) Handbook of Medical and Health Sciences in Develo** Countries. Springer, Cham. https://doi.org/10.1007/978-3-030-74786-2_58-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-74786-2_58-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74786-2
Online ISBN: 978-3-030-74786-2
eBook Packages: Springer Reference MedicineReference Module Medicine